Подтвердите e-mail

Для публикаций, комментариев, реакций и сообщений подтвердите адрес.

Профиль

Apoorva Mandavilli

Профиль Vively

Science and global health reporter for The New York Times https://www.nytimes.com/by/apoorva-mandavilli Signal: amnyt.91

I’m not sure what you mean. I shared a gift link in this very post and there indeed are comments (402 so far)

110

Gilead’s tactics may have resulted in higher drug prices but that is just one of the many issues at play here, as the article details. I have written about Gilead issues elsewhere: www.nytimes.com/2019/10/04/h...

F.D.A. Approves New H.I.V.-Prevention Drug, but Not for Everyone (Published 2019)www.nytimes.com
083

This just happened, the suit itself is not live yet, but will add once it is

0101

But just as abruptly as it was announced, it was reversed, and the pause was over. HHS told me the grants were “temporarily paused” for review. Unclear why exactly the were unpaused suddenly and whether they will be paused again, perhaps after the storm. 3/3

2224

Wide panic because the funds pay for everything from outbreak response systems to personnel. And at least in some places, would have affected response to the snowstorm. 2/3

12712

They can still opt to do it. But not having a recommendation just opens the door to more nos, from parents, doctors, hospitals, states…

010

That is correct. And the article says so. But they were not all in agreement so there were several shouting matches.

110

The link in the post is a gift article, in case you want to read the rest

010
Показать ещё